Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs

Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):845-9. doi: 10.1002/pds.1432.

Abstract

Purpose: Contradictory results were published from two studies in the late 1990s about the effects of long half-life benzodiazepine use on the risk of motor vehicle crashes (MVCs) in the elderly. The use of different study designs could explain the differences observed in these studies.

Methods: The results of an unmatched case-control study were compared to those of a case-crossover study using the same prescription claims database to determine whether the current use of benzodiazepines increased the risk of MVCs.

Results: There were 5579 cases and 12 911 controls identified between the years 1990 and 1993 in the province of Quebec, Canada. The case-control approach demonstrated an increased rate of injurious MVC associated with the current use of long-acting benzodiazepines [odds ratio (OR) 1.45; 95% confidence interval (CI): 1.12-1.88]. The case-crossover approach applied to all cases did not show any association [OR 0.99; 95%CI: 0.83-1.19]. However, among the cases restricted to subjects with four or less prescriptions filled in the previous year, corresponding more to transient exposures, the OR was elevated [OR 1.53; 95%CI: 1.08-2.16].

Conclusions: Differences in study design and analysis may explain some of the discrepancies in previous results. Both study designs provide evidence that long-acting benzodiazepines appear to be associated with an increased risk of MVC.

Publication types

  • Comparative Study

MeSH terms

  • Accidents, Traffic / statistics & numerical data*
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Automobile Driving*
  • Benzodiazepines / adverse effects*
  • Benzodiazepines / pharmacokinetics
  • Case-Control Studies
  • Central Nervous System Agents / adverse effects*
  • Central Nervous System Agents / pharmacokinetics
  • Cross-Over Studies
  • Databases, Factual
  • Epidemiologic Research Design
  • Female
  • Half-Life
  • Humans
  • Male
  • Odds Ratio
  • Pharmacoepidemiology / methods*
  • Quebec / epidemiology
  • Reproducibility of Results
  • Risk

Substances

  • Central Nervous System Agents
  • Benzodiazepines